Advanced search×

Prehospital diagnosis of ST-segment elevation myocardial infarction using an "all-posterior" 12-lead electrocardiogram.

Prehosp Emerg Care 15(3):410-3 (2011) PMID 21463202

A prehospital 12-lead electrocardiogram (ECG) is commonly used for patients with suspected ST-segment elevation myocardial infarction (STEMI). This case report describes how paramedics diagnosed inferior STEMI with all ECG leads positioned on a patient's back (i.e., "all-posterior" positioning). The patient was hemodynamically stable but morbidly obese and markedly diaphoretic. Owing to severe back pain, he refused to lie in the supine position for assessment or transport. At the emergency department, a 12-lead ECG with the patient in lateral recumbency confirmed the diagnosis of inferior STEMI. This case shows that an all-posterior 12-lead ECG can be used to identify STEMI when optimal patient positioning is not possible.

DOI: 10.3109/10903127.2011.561414
Version: za2963e q8za3 q8zbc q8zc2 q8zd0 q8zef q8zf3 q8zg2

Similar articles you may find interesting…

  1. Possibilities of poly(D,L-lactide-co-glycolide) in the formulation of nanomedicines against cancer.

    Curr Drug Targets 12(8):1096-111 (2011) PMID 21443478

    We analyze the major applications of this FDA-approved biodegradable polymer in the formulation of nanomedicines against cancer. Despite conventional PLGA colloids could be only used to target tumors located into the mononuclear phagocyte system (MPS), special strategies are under intensive research...
  2. Lipid-based drug delivery systems for cancer treatment.

    Curr Drug Targets 12(8):1151-65 (2011) PMID 21443475

    It is a fact that chemotherapy agents have little specificity for cancer cells, this leading to low concentrations into the tumor interstititum and severe side effects on healthy tissues. The formulation of lipid-based nanomedicines against cancer has been hypothesized to improve dru...
  3. Drug targeting strategies in cancer treatment: an overview.

    Mini Rev Med Chem 11(1):1-17 (2011) PMID 21235512

    Classic chemotherapy his little or no specificity for cancer cells, normally resulting in low accumulation at the tumor region (inefficacy), and in severe side effects (toxicity). This challenge has resulted in the development of several deliver strategies for chemotherapy agents to improve their co...